Ligand Pharmaceuticals | LGND - Market Capitalization


Ligand Pharmaceuticals reported $5.06B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 3.19B 3.06B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 10.84B 664M Aug/2026
Baxter International USD 11.01B 2.34B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Enviri Corporation USD 1.45B 423M Dec/2025
Gilead Sciences USD 168.68B 11.82B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 19.68B 3.43B Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Ligand Pharmaceuticals USD 5.31B 1.02B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 324.18B 6.81B Aug/2026
Pacira USD 1.28B 286M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Veracyte USD 4.69B 2.12B Jun/2026